Secarna Pharmaceuticals and Vect-Horus have announced a research collaboration aimed at developing RNA-targeted therapeutics that can cross the blood-brain barrier. This partnership combines advanced delivery technologies and oligonucleotide expertise to create potential treatments for CNS disorders.

Secarna Pharmaceuticals is a company focused on the discovery and development of best-in-class oligonucleotide therapeutics. They specialize in creating innovative solutions for RNA-targeted therapies. Their mission is to address unmet medical needs through advanced oligonucleotide technology.

https://www.secarna.com/

Therapeutics

Secarna Pharmaceuticals and Vect-Horus Form Strategic Research Partnership for RNA-Therapeutics Delivery.

Description

Company Information

Agreement Insights

Secarna Pharmaceuticals and Vect-Horus Form Strategic Research Partnership for RNA-Therapeutics Delivery.

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Agreement Insights

Company Information